Last 46 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -64.27 | 40.96 | 25.08 | — | 44.74 | — | — | 185.00 | 108.57 | 104.89 | 46.51 | 109.60 | 141.85 | 118.29 | 49.32 | 50.41 | 102.95 | 46.82 | 62.03 | 67.61 | 71.60 |
| — | — | — | — | -58.8% | — | — | +68.8% | -23.5% | -11.3% | -5.7% | +117.4% | +37.8% | +152.6% | -20.5% | -25.4% | +43.8% | -26.3% | +11.9% | +1.8% | +26.4% | |
| P/S Ratio | 6.17 | 5.82 | 4.18 | 5.18 | 6.21 | 6.02 | 3.69 | 3.58 | 4.97 | 5.86 | 2.87 | 2.47 | 4.92 | 4.44 | 3.29 | 3.48 | 3.32 | 7.15 | 12.91 | 12.69 | 11.85 |
| — | -3.4% | +13.5% | +44.5% | +25.0% | +2.8% | +28.6% | +45.2% | +1.1% | +31.9% | -12.7% | -29.0% | +47.9% | -37.8% | -74.6% | -72.6% | -72.0% | -36.8% | -2.5% | +7.2% | +12.7% | |
| P/B Ratio | 13.52 | 11.91 | 9.57 | 9.50 | 8.84 | 9.47 | 8.42 | 4.94 | 5.00 | 5.83 | 4.61 | 3.70 | 6.84 | 7.55 | 6.06 | 6.10 | 6.25 | 5.50 | 10.91 | 10.63 | 10.40 |
| — | +25.7% | +13.7% | +92.1% | +76.9% | +62.4% | +82.6% | +33.4% | -27.0% | -22.7% | -23.8% | -39.2% | +9.5% | +37.3% | -44.5% | -42.6% | -39.9% | -46.1% | -1.7% | +14.2% | +10.4% | |
| P/FCF | 47.64 | 58.71 | 32.33 | 37.78 | 35.73 | 82.99 | 46.63 | — | 25.37 | 56.69 | 30.38 | — | 1491.92 | — | — | 1909.19 | — | 10868.13 | 46.19 | 55.58 | 188.22 |
| — | -29.3% | -30.7% | — | +40.9% | +46.4% | +53.5% | — | -98.3% | — | — | — | — | — | — | +3335.3% | — | +15575.2% | -40.6% | -48.9% | +175.1% | |
| EV / EBITDA | 27.96 | 28.52 | 18.75 | 21.69 | 33.30 | 27.46 | — | 24.22 | 36.20 | 34.73 | 26.70 | 28.17 | 44.89 | 42.40 | 14.62 | 34.26 | 22.34 | 29.12 | 46.78 | 48.79 | 47.11 |
| — | +3.9% | — | -10.5% | -8.0% | -20.9% | — | -14.0% | -19.4% | -18.1% | +82.6% | -17.8% | +101.0% | +45.6% | -68.8% | -29.8% | -52.6% | -33.6% | -9.1% | +4.9% | +8.5% | |
| EV / EBIT | 31.43 | 31.51 | 22.43 | 23.79 | 38.17 | 30.81 | — | 89.76 | 45.73 | 41.59 | 48.11 | 52.25 | 66.85 | 71.34 | 33.28 | 34.26 | 66.72 | 33.84 | 52.74 | 55.42 | 53.31 |
| — | +2.3% | — | -73.5% | -16.5% | -25.9% | — | +71.8% | -31.6% | -41.7% | +44.5% | +52.5% | +0.2% | +110.8% | -36.9% | -38.2% | +25.1% | -32.4% | -6.2% | +8.2% | +12.7% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.9% | 62.1% | 60.0% | 62.1% | 62.9% | 62.9% | 40.7% | 52.2% | 60.3% | 60.8% | 47.9% | 49.0% | 48.6% | 50.4% | 50.8% | 51.4% | 45.7% | 67.3% | 65.6% | 66.2% | 63.2% |
| — | -1.2% | +47.2% | +19.0% | +4.3% | +3.4% | -14.9% | +6.4% | +24.1% | +20.7% | -5.8% | -4.7% | +6.4% | -25.1% | -22.6% | -22.4% | -27.8% | +2.2% | +3.5% | +2.9% | -0.7% | |
| Operating Margin | 20.5% | 19.2% | 20.3% | 22.5% | 17.4% | 21.0% | -59.8% | 6.0% | 12.2% | 15.6% | 8.0% | 5.3% | 6.4% | 6.7% | 11.9% | 10.0% | 3.9% | 19.6% | 23.6% | 22.0% | 21.3% |
| — | -8.5% | +134.0% | +277.3% | +42.7% | +34.1% | -845.8% | +13.4% | +89.3% | +132.5% | -32.5% | -47.3% | +64.6% | -65.7% | -49.7% | -54.6% | -81.7% | -10.6% | +7.4% | +2.4% | +3.2% | |
| Net Margin | -9.9% | 14.1% | 16.6% | -27.0% | 13.8% | -45.9% | -58.2% | 1.9% | 4.7% | 5.6% | 6.2% | 2.2% | 3.4% | 3.8% | 6.6% | 6.9% | 3.2% | 15.3% | 20.8% | 18.8% | 16.5% |
| — | +130.8% | +128.5% | -1491.6% | +197.3% | -924.5% | -1042.3% | -12.3% | +34.9% | +47.6% | -6.8% | -67.9% | +7.7% | -75.4% | -68.2% | -63.3% | -80.5% | -14.2% | -13.0% | +5.8% | -11.2% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -17.1% | 7.6% | 8.9% | -10.8% | 5.2% | -17.1% | -27.8% | 0.7% | 1.2% | 1.4% | 2.6% | 0.8% | 1.2% | 1.6% | 3.2% | 3.1% | 1.3% | 3.0% | 4.5% | 4.0% | 3.7% |
| — | +144.3% | +132.1% | -1665.9% | +340.7% | -1333.9% | -1182.6% | -15.6% | -1.6% | -13.2% | -18.7% | -73.4% | -8.5% | -46.4% | -30.2% | -23.6% | -64.8% | -23.8% | -9.7% | +12.9% | -14.0% | |
| ROA | -7.0% | 3.4% | 3.9% | -4.8% | 2.2% | -6.9% | -12.2% | 0.3% | 0.5% | 0.6% | 1.1% | 0.4% | 0.5% | 0.7% | 1.3% | 1.3% | 0.7% | 2.5% | 3.7% | 3.4% | 3.1% |
| — | +149.2% | +131.7% | -1552.0% | +299.5% | -1201.5% | -1189.7% | -7.1% | +6.7% | -6.4% | -14.0% | -72.0% | -31.1% | -72.6% | -65.1% | -62.4% | -75.7% | -23.9% | -9.4% | +13.6% | -14.6% | |
| ROIC | 16.5% | 5.1% | 5.7% | 4.8% | 3.2% | 3.6% | -13.9% | 1.1% | 1.5% | 1.8% | 1.5% | 0.9% | 1.0% | 1.3% | 2.6% | 2.0% | 1.1% | 5.2% | 6.9% | 6.0% | 5.9% |
| — | +40.1% | +141.1% | +353.0% | +117.0% | +98.3% | -1007.8% | +20.1% | +44.0% | +39.2% | -41.2% | -56.5% | -11.1% | -74.4% | -62.3% | -66.0% | -80.5% | -15.7% | +11.4% | +0.9% | -11.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.78 | 0.62 | 0.78 | 0.72 | 0.62 | 0.72 | 0.80 | 0.59 | 0.63 | 0.70 | 0.71 | 0.78 | 0.75 | 0.76 | 0.77 | 0.83 | 0.83 | 0.02 | 0.02 | 0.02 | 0.03 |
| — | -14.5% | -3.6% | +23.0% | -2.4% | +2.7% | +13.2% | -24.9% | -16.3% | -7.4% | -7.5% | -5.5% | -9.6% | +2979.5% | +3542.7% | +3519.7% | +3195.9% | -8.0% | -13.6% | +13.4% | +25.2% | |
| Debt / EBITDA | 1.59 | 5.68 | 5.74 | 6.39 | 8.81 | 7.87 | — | 10.51 | 16.51 | 15.16 | 14.59 | 20.11 | 18.08 | 15.71 | 6.73 | 16.83 | 10.79 | 0.57 | 0.38 | 0.44 | 0.48 |
| — | -27.8% | — | -39.3% | -46.6% | -48.1% | — | -47.7% | -8.7% | -3.5% | +116.6% | +19.5% | +67.5% | +2679.3% | +1682.7% | +3744.0% | +2166.7% | +18.1% | -19.7% | +3.2% | +21.7% | |
| Current Ratio | 2.49 | 2.68 | 2.49 | 2.84 | 2.14 | 2.17 | 1.98 | 2.01 | 2.09 | 2.31 | 2.18 | 2.14 | 2.11 | 2.16 | 2.08 | 2.12 | 2.10 | 4.82 | 4.63 | 4.98 | 4.78 |
| — | +23.5% | +25.6% | +41.3% | +2.6% | -6.3% | -9.2% | -6.1% | -1.0% | +6.9% | +5.2% | +0.8% | +0.7% | -55.1% | -55.1% | -57.5% | -56.1% | -3.6% | -1.8% | +0.1% | -0.4% | |
| Quick Ratio | 1.47 | 1.45 | 1.47 | 1.92 | 1.61 | 1.62 | 1.24 | 1.11 | 1.15 | 1.31 | 1.22 | 1.13 | 1.16 | 1.30 | 1.28 | 1.28 | 1.28 | 3.98 | 3.87 | 4.10 | 3.84 |
| — | -10.5% | +18.3% | +72.4% | +39.5% | +23.5% | +1.9% | -1.3% | -1.0% | +0.7% | -5.0% | -11.7% | -9.4% | -67.3% | -66.9% | -68.8% | -66.6% | +2.1% | +2.3% | -0.0% | -6.8% | |
| Interest Coverage | 9.21 | 12.69 | 10.87 | 9.51 | 7.76 | 8.77 | -35.17 | 2.10 | 3.76 | 4.39 | 2.67 | 2.09 | 3.10 | 3.20 | 5.89 | 6.36 | 6.91 | 592.00 | 800.00 | 777.01 | 653.00 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 46 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MASI stock.
Masimo Corporation's current P/E is -64.3x. The average P/E over the last 3 quarters is 36.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Masimo Corporation's current operating margin is 20.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Masimo Corporation's business trajectory between earnings reports.